New Matter Podcast

Current Episode

In this week's episode, we delve into AI adoption in early drug discovery with Raminderpal Singh, Ph.D., founder of HitchhikersAI. Raminderpal shares insights into HitchhikersAI's mission which focuses on providing a collaborative platform for leveraging AI in drug discovery, emphasizing simple and effective solutions over complexity. He discusses the distinction between popularization and democratization of AI tools and highlights the importance of making solutions widely accessible while addressing specific needs in the open-source community.

Take the Biotech Pain Points Survey

Our Sponsor for this Episode: Roche
At Roche Sequencing, we are building on Roche’s legacy of innovation to transform next-generation sequencing and its application. By simplifying workflows and expanding assay menus, we are broadening access to genomic data and lowering barriers to routine use. Our growing suite of products spans the genomics workflow, from sample acquisition and preparation through data analysis and final result, helping you answer important questions in genetics, cancer and beyond.

We’re not just committed to providing you with our broad portfolio of industry-leading sequencing solutions; we’re also dedicated to making sure that you have the scientific support, technical expertise, and guidance that you can depend on. So, no matter what your sequencing destination, you can be sure we’re with you every step of the way.